Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow HUM
Humana Inc. (HUM) Return on assets
Humana Inc.'s return on assets over the twelve months to 30 June 2026 was 2.38%, down 0.1 percentage points from fiscal 2025 (2.49%). Over the past ten years it has ranged from 2.45% (fiscal 2016) to 10.5% (fiscal 2020); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 2.98% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 2.49% | (0.09) |
| FY2024 | 2.58% | (2.94) |
| FY2023 | 5.52% | (0.90) |
| FY2022 | 6.42% | (0.97) |
| FY2021 | 7.39% | (3.12) |
| FY2020 | 10.5% | 0.57 |
| FY2019 | 9.94% | 3.54 |
| FY2018 | 6.40% | (2.91) |
| FY2017 | 9.31% | 6.86 |
| FY2016 | 2.45% | (2.84) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| OSCR Oscar Health, Inc. compare | 6.25% |
| UNH UnitedHealth Group Incorporated compare | 5.06% |
| CI Cigna Group compare | 4.16% |
| ELV Elevance Health, Inc. compare | 4.00% |
| HUM Humana Inc. | 2.38% |
| CVS CVS Health Corporation compare | 1.91% |
| MOH Molina Healthcare, Inc compare | −0.04% |
| CLOV Clover Health Investments, Corp. compare | −2.84% |
| CNC Centene Corporation compare | −6.02% |
| Healthcare Plans industry median | 2.98% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement